BRIEF-Biogen down in premarket after drug trial results

NEW YORK Thu Jan 3, 2013 7:42am EST

NEW YORK Jan 3 (Reuters) - Biogen Idec Inc : * Shares down 5.8 percent in premarket trading after drug trial results

FILED UNDER: